This is an application for the renewal of a senior scientist research and mentorship award to provide protected time for Ken Mackie so he can achieve the following goals for his research, mentoring, and career development. Specific research objectives during the next five years include: (1) Obtaining a comprehensive understanding of the mechanisms of CB1 cannabinoid receptor desensitization, (2) Discerning the roles of endogenous and exogenous cannabinoids during two key neurodevelopmental stages (A) during embryonic life and (B) during the adolescent maturation of the prefrontal cortex, (3) Exploring the therapeutic potential of CB2 cannabinoid receptor functional selectivity in making more effective analgesics and in attenuating cocaine reward, (4) Using simplified experimental systems (primarily cultured autaptic neurons) to address significant, outstanding issues in endocannabinoid-mediated synaptic plasticity. Dr. Mackie's mentoring will focus on mentoring four groups of scientists that encompass the full career spectrum: undergraduates at Indiana University, graduate and medical students at Indiana University, post-doctoral fellows, and junior faculty. His career development will emphasize the incorporation of more powerful imaging, informatic, proteomic, and behavioral tools into his research, as well as continuing to be heavily committed to service (editorial duties, meeting organization, and grant reviews) related to drug abuse research.

Public Health Relevance

This application for a Senior Scientist Research and Mentorship Award seeks protected time for Ken Mackie, MD so that he may pursue research into the mechanisms of action of cannabis and endogenous cannabinoids and the consequence of their regular use. In the process of this he will also be mentoring students and faculty as they become drug abuse researchers.

National Institute of Health (NIH)
National Institute on Drug Abuse (NIDA)
Research Scientist Award (K05)
Project #
Application #
Study Section
Molecular Neuropharmacology and Signaling Study Section (MNPS)
Program Officer
Pollock, Jonathan D
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Indiana University Bloomington
Schools of Arts and Sciences
United States
Zip Code
Deng, Liting; Guindon, Josée; Cornett, Benjamin L et al. (2015) Chronic cannabinoid receptor 2 activation reverses paclitaxel neuropathy without tolerance or cannabinoid receptor 1-dependent withdrawal. Biol Psychiatry 77:475-87
Wu, Chia-Shan; Morgan, Daniel; Jew, Chris P et al. (2014) Long-term consequences of perinatal fatty acid amino hydrolase inhibition. Br J Pharmacol 171:1420-34
Flores-Otero, Jacqueline; Ahn, Kwang H; Delgado-Peraza, Francheska et al. (2014) Ligand-specific endocytic dwell times control functional selectivity of the cannabinoid receptor 1. Nat Commun 5:4589
Ramikie, Teniel S; Nyilas, Rita; Bluett, Rebecca J et al. (2014) Multiple mechanistically distinct modes of endocannabinoid mobilization at central amygdala glutamatergic synapses. Neuron 81:1111-25
Lutomski, Corinne A; El-Baba, Tarick J; Inutan, Ellen D et al. (2014) Transmission geometry laserspray ionization vacuum using an atmospheric pressure inlet. Anal Chem 86:6208-13
Lazenka, Matthew F; Selley, Dana E; Sim-Selley, Laura J (2014) ?FosB induction correlates inversely with CB? receptor desensitization in a brain region-dependent manner following repeated ??-THC administration. Neuropharmacology 77:224-33
Melis, Miriam; Sagheddu, Claudia; De Felice, Marta et al. (2014) Enhanced endocannabinoid-mediated modulation of rostromedial tegmental nucleus drive onto dopamine neurons in Sardinian alcohol-preferring rats. J Neurosci 34:12716-24
Morgan, Daniel J; Davis, Brian J; Kearn, Chris S et al. (2014) Mutation of putative GRK phosphorylation sites in the cannabinoid receptor 1 (CB1R) confers resistance to cannabinoid tolerance and hypersensitivity to cannabinoids in mice. J Neurosci 34:5152-63
Lovelace, Jonathan W; Vieira, Philip A; Corches, Alex et al. (2014) Impaired fear memory specificity associated with deficient endocannabinoid-dependent long-term plasticity. Neuropsychopharmacology 39:1685-93
Murataeva, N; Straiker, A; Mackie, K (2014) Parsing the players: 2-arachidonoylglycerol synthesis and degradation in the CNS. Br J Pharmacol 171:1379-91

Showing the most recent 10 out of 71 publications